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The Pseudomonas syringae type III secretion system (TTSS) translocates effector proteins into plant cells.
Several P. syringae effectors require accessory proteins called type III chaperones (TTCs) to be secreted via the
TTSS. We characterized the hopO1-1, hopS1, and hopS2 operons in P. syringae pv. tomato DC3000; these
operons encode three homologous TTCs, ShcO1, ShcS1, and ShcS2. ShcO1, ShcS1, and ShcS2 facilitated the
type III secretion and/or translocation of their cognate effectors HopO1-1, HopS1, and HopS2, respectively.
ShcO1 and HopO1-1 interacted with each other in yeast two-hybrid and coimmunoprecipitation assays.
Interestingly, ShcS1 and ShcS2 were capable of substituting for ShcO1 in facilitating HopO1-1 secretion and
translocation and each TTC was able to bind the other’s cognate effectors in yeast two-hybrid assays. Moreover,
ShcO1, ShcS1, and ShcS2 all bound to the middle-third region of HopO1-1. The HopS2 effector possessed
atypical P. syringae TTSS N-terminal characteristics and was translocated in low amounts. A site-directed
HopS2 mutation that introduced a common N-terminal characteristic from other P. syringae type III secreted
substrates increased HopS2 translocation, supporting the idea that this characteristic functions as a secretion
signal. Additionally, hopO1-2 and hopT1-2 were shown to encode effectors secreted via the DC3000 TTSS.
Finally, a DC3000 hopO1-1 operon deletion mutant produced disease symptoms similar to those seen with
wild-type DC3000 but was reduced in its ability to multiply in Arabidopsis thaliana. The existence of TTCs that
can bind to dissimilar effectors and that can substitute for each other in effector secretion provides insights into
the nature of how TTCs function.
Pseudomonas syringae is a gram-negative bacterial pathogen
that is capable of causing disease in many different plants (4,
38). The complete genome sequence of P. syringae pv. tomato
DC3000, a pathogen of tomato and the model plant Arabidop-
sis thaliana, has been determined (15). To be pathogenic, P.
syringae requires a type III protein secretion system (TTSS)
known as the Hrp system, which is encoded by the Hrp patho-
genicity island (3, 5). TTSSs “inject” or translocate bacterial
proteins called effectors into host cells and are present in many
gram-negative pathogens of plants, animals, and insects and
other bacteria closely associated with eukaryotes (22, 39).
In addition to translocating effectors, the P. syringae TTSS
also secretes extracellular accessory proteins or helper proteins
in the extracellular spaces of plant leaves (i.e., the apoplast),
which help in the translocation of effectors into plant cells. P.
syringae effectors and helper proteins have been named Hop
proteins (for “Hrp outer proteins”). The secretion signals or
recognition motifs for proteins secreted by TTSSs are encoded
within the N-terminal half of TTSS substrates, with the N-
terminal 15 to 20 amino acids being particularly important (62,
63, 66). Specifically, amphipathicity within the N-terminal 15
amino acids appears to be an important characteristic for se-
cretion of Yersinia TTSS substrates (51, 52). P. syringae Hops
also share biochemical characteristics that may be part of an
N-terminal secretion signal recognized by the TTSS apparatus.
For example, the first 50 amino acids are rich in Ser residues
and other polar amino acids; position 3 or 4 in most Hops is
occupied by aliphatic amino acids (Ile, Leu, Val) or Pro; and
the first 12 amino acids rarely have any acidic amino acids (Glu
and Asp) (34, 59). However, it remains unknown whether these
shared biochemical characteristics are functionally important
for the type III secretion of P. syringae Hops.
The availability of the P. syringae pv. tomato DC3000 ge-
nome sequence has spurred several bioinformatic and func-
tional genomic searches for additional DC3000 hop genes (21,
33). These studies have exploited the fact that most TTSS-
related genes in P. syringae have promoters that contain a
conserved sequence called a Hrp box, which is the presumed
binding site for HrpL, an alternate sigma factor (30, 73, 75).
Additional hop genes were identified based on the biochemical
characteristics in the N termini of their predicted products (34,
59). The confirmed Hop inventory of DC3000 is now greater
than 40 and is likely to become even larger as additional pu-
tative Hops are shown to be secreted or translocated through
the TTSS (6). The pathogenic roles for the majority of these
Hops are poorly understood, although recently many P. syrin-
gae effectors have been implicated in suppression of plant
innate immunity (1, 2, 7, 14, 25–27, 36, 42, 55). Recently, a
unified naming system for P. syringae Hops has been estab-
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lished and this naming system will be used for the effectors
described in this paper (50).
Many TTSS substrates utilize intracellular accessory pro-
teins called type III chaperones (TTCs) that facilitate their
secretion and translocation via the TTSS (6, 28, 58). TTCs
generally do not share significant sequence similarity with each
other unless they are homologous TTCs from different bacte-
rial strains. But they do share the following general character-
istics: a low molecular mass (about 10 to 20 kDa); an acidic
isoelectric point (pI  6); and a C-terminal amphipathic re-
gion. Several classes of TTCs have been described (58). Class
IA TTCs associate with one effector and are usually encoded
by TTC genes that are next to their cognate effector gene; class
1B TTCs associate with multiple effectors and are encoded by
genes within the DNA regions encoding the TTSS apparatus;
class II TTCs assist in the type III secretion of translocators, a
class of helper proteins that assist effectors in crossing the
eukaryotic plasma membrane; and class III TTCs are utilized
in the related flagellar biogenesis TTSS.
The roles of TTCs appear to be multidimensional. TTCs
have been shown to prevent interactions between TTSS sub-
strates in the bacterial cell (57, 74) and to stabilize effectors
(28, 31). In addition, TTCs may help establish an order of
effector secretion (12, 69) and several TTCs play a regulatory
role (17, 24, 56, 72). The binding sites for most TTCs are on the
N-terminal half of TTSS substrates and may provide a second
secretion signal for effectors to be recognized by the secretion
apparatus (20). Recently, it has been shown that TTCs in
Salmonella spp. are involved in TTSS specificity by directing
substrates to a specific TTSS (49). The crystal structure of
several TTCs has been determined, including several bound to
binding domains of their cognate effectors (68). The majority
of these TTCs possess a similar structure and bind to their
substrate binding sites as a homodimer (9, 10, 54, 65). Inter-
estingly, the crystal structure of an Escherichia coli TTC sub-
strate pair, CesA-EspA, revealed a distinct structure and CesA
was shown to bind EspA as a monomer (74).
TTCs have been confirmed to function in the TTSSs of the
bacterial plant pathogens Erwinia amylovora (DspB) (31) and
Xanthomonas campestris pv. vesicatoria (HpaB) (16), as well as
several in P. syringae (ShcA, ShcF, ShcM, ShcN, and ShcV) (8,
53, 64, 70, 71). All of the TTCs identified in plant pathogens
thus far belong to class IA, with the exception of HpaB, a class
IB member. Of the TTCs confirmed in P. syringae, all but one,
ShcA, is from DC3000, though an uncharacterized ShcA is also
present in DC3000 (15, 71). Several other candidate TTCs
have been identified in DC3000 on the basis of the general
TTC characteristics and gene location (15, 34, 70, 71). One of
the DC3000 TTC genes, shcO1, is in the hopO1-1 operon and
is likely a TTC for the HopO1-1 effector (formerly known as
HopPtoO or HopPtoS1) (34, 59). The hopO1-1 operon has
been shown to be actively transcribed (11, 75). Two other
DC3000 operons have TTC genes homologous to shcO1 (33).
One of these operons, the hopS1 operon, contains shcS1, en-
coding a putative TTC for the confirmed effector HopS1 (for-
merly HopPtoS4) (62). The other operon, the hopS2 operon,
contains a TTC gene homologous to shcO1 and is an apparent
two-gene operon, which contains the putative TTC gene shcS2
and putative effector gene hopS2. Recent translocation exper-
iments suggested that HopS2 was not translocated (62). The
hopO1-1, hopS1, and hopS2 operons also share homologies
between their confirmed and/or putative effector genes (33).
In this study we characterized the hopO1-1, hopS1, and
hopS2 operons from DC3000 and confirmed that two novel
Hops, HopO1-2 and HopT1-2, are secreted via the TTSS. We
showed that ShcO1, ShcS1, and ShcS2 act as TTCs for their
cognate effectors, HopO1-1, HopS1, and HopS2, respectively.
ShcS1 and ShcS2 can substitute for ShcO1 and enhance the
type III secretion and translocation of the HopO1-1 effector.
We delimited the TTC binding site within HopO1-1 for each of
these TTCs and found that each interacted with the middle
third of HopO1-1 in yeast two-hybrid assays. Interestingly, we
found HopS2 was translocated at a low level into plant cells
and when a common N-terminal characteristic present in other
Hops was introduced into HopS2, the translocation of HopS2
increased, suggesting that this characteristic is functionally im-
portant for TTSS substrate secretion.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used are listed in Table 1. Escherichia coli strains were grown routinely
in LM (35) or Terrific (61) broth at 37°C. P. syringae strains were grown in KB
broth (46) at 30°C. For type III secretion assays, P. syringae pv. tomato DC3000
strains were grown in hrp-inducing fructose medium at 22°C (41). Antibiotics
were used at the following concentrations: ampicillin (Ap), 100 g ml1; chlor-
amphenicol (Cm), 30 g ml1; gentamicin (Gm), 10 g ml1; kanamycin (Km),
50 g ml1; rifampin (Rif), 100 g ml1; spectinomycin (Sp), 50 g ml1; and
tetracycline (Tc), 20 g ml1.
General DNA manipulations. For standard molecular biological manipula-
tions, well-described protocols were used (61). Restriction enzymes, T4 ligase,
and DNA polymerase were purchased from New England Biolabs (Beverly,
Mass.). The thermostable DNA polymerase used in PCRs was Pfu polymerase
(Stratagene, La Jolla, Calif.). Oligonucleotide primers were ordered from Inte-
grated DNA Technologies (Coralville, Iowa). For cloning using Gateway tech-
nology, we amplified desired target genes using PCR and Pfu polymerase and
cloned the amplified fragments into the pENTR/D-TOPO vector (Invitrogen,
Carlsbad, Calif.). The resulting pENTR constructs were recombined with Gate-
way destination vectors by LR reaction using LR clonase (Invitrogen) following
the manufacturer’s instructions. Information on the primers used for PCR clon-
ing is provided at the following URL: http://psiweb.unl.edu/alfano/tables
/Table51.pdf. The standard cycling conditions used for PCRs were as follows: 2
min at 94°C; 30 cycles of 1 min at 94°C, 1 min at 50°C, and 1 min at 72°C; and
1 cycle for 10 min at 72°C. Plasmids were introduced into P. syringae strains by
electroporation. General DNA sequence analysis was performed with Lasergene
software (DNAstar Inc., Madison, Wis.). Database searches were done with
BLASTN, BLASTP, BLASTX (http://www.ncbi.nlm.nih.gov/BLAST/index.html), and
3D-PSSM (http://www.sbg.bio.ic.ac.uk/3dpssm/).
Type III protein secretion assays. To clone shcS1 and shcS2 separately into the
BamHI site of pLN142 we used primers sets P1308/1309 and P1306/P1307,
respectively, resulting in constructs pLN1019 and pLN1018. To clone hopO1-2-
flag into pML123 we used primer set P1093/P821 (which contained either a ClaI
or a XhoI site), resulting in pLN521. Primer set P823/P824 (which contained
either a XbaI or BamHI site) was used to clone hopT1-2-flag, resulting in
construct pLN567. These constructs were transformed into DC3000(pCPP2318)
or UNL137(pCPP2318) by electroporation and used for secretion assays.
pCPP2318 encodes a mature -lactamase and should remain cell bound and was
used as a lysis control. In other secretion assays, NPTII was used as a lysis
control. Secretion assays were performed as previously described (59). Briefly,
bacterial strains were grown at 22°C in hrp-inducing conditions for 4 to 6 h. Cell
and supernatant fractions were separated with centrifugation. Proteins in the
supernatants were precipitated with trichloroacetic acid and resuspended in 1
sample sodium dodecyl sulfate (SDS) buffer. The cell and supernatant fraction
preparations resulted in 13.3- and 133-fold concentrations, respectively, relative
to initial volumes. Equal volumes of each sample were separated by SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE) using standard procedures (61),
transferred to polyvinylidene difluoride membranes, and immunoblotted with
anti-FLAG (Sigma Chemical Co., St. Louis, Mo.), anti-NPTII (Cortex Biochem,
San Leandro, Calif.), or anti--lactamase or anti-hemagglutinin (HA) (Roche
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TABLE 1. Strains and plasmids used in this study
Strain or plasmid Characteristics Reference and/or source
Strains
E. coli DH5	 supE44 
lacU169(80lacZ
M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1, Nalr 35; Life Technologies
E. coli DB3.1 F gyrA462 endA1 
(sr1-recA) mcrB mrr hsdS20 (rB
, mB
) supE44 ara-14 galK2 lacY1
proA2 rpsL20 (Smr) xyl-5  leu mtl-1
Invitrogen
P. syringae pv. tomato DC3000 Wild type; spontaneous Rifr 23
P. syringae pv. syringae B728A Wild type; spontaneous Rifr 37
P. syringae pv. tomato UNL137 DC3000 hopO1-1 operon deletion mutant, Rifr Spr This work
Plasmids
pBluescript-II KS Cloning vector, Apr Stratagene
pML123 Broad-host-range cloning vector, Gmr Kmr 48
pBBR1MCS1 Broad-host-range vector, Cmr 47
pRK415 Broad-host-range vector, unstable in absence of selection, Tcr 45
pEG202 Yeast two-hybrid vector, creates fusion to LexA DNA binding domain, Apr 32
pJG4-5 Yeast two-hybrid vector, creates fusion to B42 activation domain, Apr 32
pENTR/D-TOPO Gateway system donor vector, Kmr Invitrogen
pCPP2318 pCPP30 derivative carrying blaM lacking signal peptide sequences, Tcr 19
pCPP3234 Gateway destination vector containing the adenylate cyclase (cyaA) gene for
C-terminal fusions, Spr/Smr Cmr
62
pLN142 pML123 derivative carrying hopO1-1-flag, Gmr 59
pLN241 pJG4-5 derivative carrying hopT1-1, Apr This work
pLN248 pJG4-5 derivative carrying hopO1-1, Apr This work
pLN249 pEG202 derivative carrying shcO1, Apr This work
pLN250 pJG4-5 derivative carrying shcO1, Apr This work
pLN256 pML123 derivative carrying hopT1-1-flag, Gmr This work
pLN314 pBluescript-II KS derivative containing 1.6 kb DNA region upstream of shcO1,
omega cassette, and 2.0 kb DNA region downstream of hopT1-1, Apr Spr
This work
pLN366 pENTR/D-TOPO derivative carrying hopS2, Kmr This work
pLN367 pENTR/D-TOPO derivative carrying hopS1, Kmr This work
pLN370 pRK415 derivative containing upstream and downstream flanking sequences of
hopO1-1 operon with omega cassette in between, Tcr Spr
This work
pLN411 pML123 derivative carrying shcO1/hopO1-1-flag, Gmr This work
pLN428 pJG4-5 derivative carrying hopO1-2, Apr This work
pLN454 pBBR1MCS5 derivative carrying hopO1-1 operon, Gmr This work
pLN521 pML123 derivative carrying hopO1-2-flag, Gmr This work
pLN567 pML123 derivative carrying hopT1-2-flag, Gmr This work
pLN568 pEG202 derivative carrying shcS1, Apr This work
pLN622 pENTR/D-TOPO derivative carrying shcS2lhopS2, Kmr This work
pLN625 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-11-140, Ap
r This work
pLN627 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-1141-283, Ap
r This work
pLN705 pBBR1MCS1 Gateway destination vector containing a hemagglutinin tag for C-
terminal fusions, Cmr
This work
pLN716 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-1190-283, Ap
r This work
pLN750 pJG4-5 derivative carrying shcS1, Apr This work
pLN752 pJG4-5 derivative carrying hopT1-2, Apr This work
pLN753 pJG4-5 derivative carrying hopS1, Apr This work
pLN786 pENTR/D-TOPO derivative carrying shcO1, Kmr This work
pLN814 pENTR/D-TOPO derivative carrying hopO1-1, Kmr This work
pLN898 Gateway construct made by recombining pLN705 and pLN786, Cmr This work
pLN966 pEG202 derivative carrying shcS2, Apr This work
pLN967 pJG4-5 derivative carrying hopS2, Apr This work
pLN980 pJG4-5 derivative carrying shcS2, Apr This work
pLN998 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-1111-175, Ap
r This work
pLN999 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-171-189, Ap
r This work
pLN1003 pENTR/D-TOPO derivative carrying shcS1/hopS1, Kmr This work
pLN1005 Gateway construct made by recombining pCPP3234 and pLN1003, Spr This work
pLN1006 Gateway construct made by recombining pCPP3234 and pLN367, Spr This work
pLN1018 pML123 derivative carrying shcS2-ha/hopO1-1-flag, Gmr This work
pLN1019 pML123 derivative carrying shcS1-ha/hopO1-1-flag, Gmr This work
pLN1022 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-11-125, Ap
r This work
pLN1023 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-11-110, Ap
r This work
pLN1027 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-1161-283, Ap
r This work
pLN1063 pENTR/D-TOPO derivative carrying shcO1/hopO1-1, Kmr This work
pLN1064 pENTR/D-TOPO derivative carrying shcS2-ha/hopO1-1, Kmr This work
pLN1065 pENTR/D-TOPO derivative carrying shcS1-ha/hopO1-1, Kmr This work
pLN1074 Gateway construct made by recombining pCPP3234 and pLN1063, Spr This work
pLN1075 Gateway construct made by recombining pCPP3234 and pLN1064, Spr This work
pLN1076 Gateway construct made by recombining pCPP3234 and pLN1065, Spr This work
Continued on following page
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Diagnostics Corp., Indianapolis, Ind.) primary antibodies. Anti--lactamase and
anti-NPTII antibodies were recognized with goat anti-rabbit immunoglobulin
G-alkaline phosphatase conjugate (Sigma Chemical Co., St. Louis, Mo.), anti-
FLAG antibodies were recognized with goat anti-mouse immunoglobulin G-
alkaline phosphatase conjugate (Sigma Chemical Co.), and anti-HA antibodies
were recognized with goat anti-rat immunoglobulin G-alkaline phosphatase con-
jugate (Sigma Chemical Co.). Membrane-bound secondary antibodies were vi-
sualized on autoradiograms with a Western Star chemiluminescence detection
kit (Applied Biosystems, Foster City, Calif.).
Coimmunoprecipitation assays with ShcO1 and HopO1-1. A Gateway entry
construct pLN786 containing shcO1 was recombined with pLN705 (a broad-host-
range Gateway destination vector), resulting in pLN898, which encodes ShcO1
fused with a C-terminal HA epitope. We electroporated a control vector or
pLN898 into DC3000(pLN142) and pLN898 into DC3000(pML123) and used
these strains to perform coimmunoprecipitation experiments. Briefly, saturated
overnight cultures were inoculated in 500 ml KB cultures and grown to an optical
density at 600 nm (OD600) of 0.8. The cells were harvested by centrifugation for
30 m at 5,000  g, and the pelleted cells were frozen at 20°C until needed. The
cells were thawed at room temperature for 30 m. The cells were resuspended in
10 ml of TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.6) with complete protease
inhibitor cocktails (Roche Diagnostics Corp., Indianapolis, Ind.). The cell sus-
pensions were lysed on ice by sonicating three times for 30 s each time and
centrifuged. Cell-free supernatants were transferred to fresh tubes, and the
aliquots were stored at 80°C until needed. Total protein (500 g) from each
sample was incubated with 100 l M2 anti-FLAG resin (Sigma Chemical Co.)
and rocked at 4°C overnight. The resin was briefly centrifuged, washed twice with
TBS, and resuspended in 100 l 1 SDS sample buffer. Samples from different
stages of the procedure along with final eluate were analyzed with immunoblots
using either anti-HA or anti-FLAG antibodies.
RNA isolation and RT-PCR analysis. DC3000 was grown in hrp-inducing
minimal or KB media to an OD600 of 0.6. Cells were harvested and lysed with
RLT buffer (QIAGEN, Valencia, CA) containing guanidinium thiocyanate
(GITC) and 1% -mercaptoethanol followed by an incubation with GITC-sat-
urated hot phenol (pH 5 to 6) at 65°C for 10 min. Total RNA was precipitated
with ammonium acetate and ethanol and resuspended in water. RNA was
treated with DNase I (Ambion, Austin, TX) as recommended by the manufac-
turer. Reverse transcription was performed with 2 g of total RNA using gene
specific primers and a RETROScript reverse transcriptase PCR (RT-PCR) kit
(Ambion). The fragments corresponding to shcS1/hopS1, hopO1-2, and shcS2/
hopS2 were amplified from the resulting cDNA by PCR with the primer sets
P933/P949, P1260/P615, and P763/P745, respectively, using the following cycling
conditions: 5 min at 94°C; 30 cycles of 30 s at 94°C, 1 min at 52°C, and 3 min at
72°C; and 1 cycle at 10 min at 72°C.
Site-directed mutagenesis of PSPTO4588 (HopS2). Site-directed mutagenesis
of hopS2 was performed using a QuikChange mutagenesis kit (Stratagene) ac-
cording to the manufacturer’s instructions. Primers P1279 and P1280 were used
in PCRs to change the fourth residue of HopS2 from a Ser to Ile (S4I). The
template DNA used was construct pLN622, which contained hopS2 with its
chaperone gene shcS2, and resulted in Gateway entry construct pLN1090. This
Gateway entry construct was recombined into pCPP3234, a broad-host-range
Gateway destination vector (62). The resulting construct, pLN1140, contained a
site-directed mutation in hopS2 which altered residue 4 (S4I) of HopS2. Addi-
tionally, another Gateway entry construct, pLN1245, was made using pLN316 as
the template DNA and primer set P1279/P1280, which lacked shcS2 and encoded
a HopS2 derivative that had the S4I mutation. This construct was recombined
with destination vector pCPP3234, resulting in construct pLN1243.
Adenylate cyclase (cyaA) translocation assay. pENTR/D-TOPO plasmids con-
taining hopO1-1 (pLN814), hopS1 (pLN367), shcS1/hopS1 (pLN1003), hopS2
(pLN366), or shcS2/hopS2 (pLN622) were recombined with pCPP3234, which
resulted in the construct pLN1077, pLN1006, pLN1005, pLN1233, or pLN1138,
respectively. To clone shcO1/hopO1-1 we used primer set P1102 and P0814 and
pLN411 as the template DNA. The amplified product was recombined into
pENTR/D-TOPO, resulting in construct pLN1063. Similarly, to clone shcS1/
hopO1-1 into pENTR/D-TOPO we used primer set P1104 and P0814 and
pLN1018 as the template, resulting in construct pLN1065. Finally, to clone
shcS2/hopO1-1, we used primer set P1106/P0814 and pLN1018 as the template
DNA, resulting in construct pLN1064. These constructs were used in Gateway
LR reactions with pCPP3234, generating pLN1074 (shcO1/hopO1-1), pLN1075
(shcS2/hopO1-1), and pLN1076 (shcS1/hopO1-1).
Each construct that encoded CyaA fusions was introduced into P. syringae pv.
syringae B728a or DC3000 by electroporation. For CyaA assays we followed a
protocol recently described (62). Briefly, bacterial suspensions in 5 mM MES
(morpholineethanesulfonic acid) (pH 5.6, containing100 M IPTG [isopropyl-
-D-thiogalactopyranoside]) at an OD600 of 0.4 were infiltrated into Nicotiana
benthamiana leaves. Disks of leaf tissue 0.9 cm in diameter were harvested 6 h
after infiltration and ground with a mortar and pestle in liquid nitrogen and
resuspended in 0.1 M HCl. A direct cyclic AMP (cAMP) correlate enzyme
immunoassay kit (Assay Designs, Ann Abor, MI) was used to measure cAMP
concentrations in each sample by following the manufacturer’s instructions.
DNA gel blots. Total DNAs (3 g) from different bacterial strains were di-
gested with EcoRI, separated in a 1% agarose gel, and transferred to an Immo-
bilon-Ny membrane (Millipore, Bedford, MA) by following a standard proto-
col (61). hopS2 DNA was PCR amplified with primers P615 and P617 and used
for a probe prepared with a Prime-It random priming labeling kit (Stratagene, La
Jolla, CA). Hybridization was carried out at 55°C in hybridization buffer (7%
SDS, 2 mM EDTA, and 0.5 M Na2HPO4) for 18 h. After hybridization the
membranes were washed twice with wash solution (0.1% SDS and 1 SSC [1
SSC is 0.15 M NaCl plus 0.015 M sodium citrate]) and exposed to X-ray films for
12 h at 80°C.
Construction of the DC3000 hopO1-1 operon mutant UNL137. DC3000 dele-
tion mutants lacking the hopO1-1 operon were made using homologous recom-
bination techniques, which replaced the operon with an antibiotic marker. To do
this, we cloned a 1.6 kb DNA region upstream of shcO1 (with primers P0574 and
P0575) and a 1.6 kb DNA region downstream of hopT1-1 (with primers P0576
and P0577) adjacent to each other in the same orientation into pBluescript SK
(Stratagene). A 2 kb Sp/Smr  fragment from pHP45 (29) was cloned into a
BamHI site in between the above-described fragments, resulting in construct
pLN314. The 5.2 kb fragment containing the hopO1-1 operon flanking regions
with the  fragment was cut out with restriction enzymes and cloned into the
XbaI and KpnI sites of pRK415 (45), resulting in construct pLN370. pLN370 was
transformed into DC3000 by electroporation and retention of the  fragment,
and loss of the plasmid was selected by growing DC3000(pLN370) cultures for 5
consecutive days in which each day a new culture was inoculated in fresh KB
broth containing Sp. On the 5th day, the culture was plated onto KB plates
TABLE 1—Continued
Strain or plasmid Characteristics Reference and/or source
pLN1077 Gateway construct made by recombining pCPP3234 and pLN814, Spr This work
pLN1090 pENTR/D-TOPO derivative carrying shcS2/hopS2 containing an S4I site-directed
mutation in HopS2, Kmr
This work
pLN1138 Gateway construct made by recombining pCPP3234 and pLN622, Spr This work
pLN1140 Gateway construct made by recombining pCPP3234 and pLN1090, Spr This work
pLN1233 Gateway construct made by recombining pCPP3234 and pLN366, Spr This work
pLN1234 pENTR/D-TOPO derivative carrying shcS2/hopS2 from P. syringae pv. tomato PT23 This work
pLN1235 pENTR/D-TOPO derivative carrying shcS2/hopS2 from P. syringae pv. maculicola 84-67 This work
pLN1236 pENTR/D-TOPO derivative carrying shcS2/hopS2 from P. syringae pv. maculicola
NCPPB1886
This work
pLN1243 Gateway construct made by recombining pCPP3234 and pLN1245, Spr This work
pLN1245 pENTR/D-TOPO derivative carrying hopS2 containing an S4I site-directed mutation in
HopS2, Kmr
This work
pLN1460 pJG4-5 derivative carrying hopO1-1 fragment corresponding to HopO1-11-70, Ap
r This work
4260 GUO ET AL. J. BACTERIOL.
containing Sp, and Spr colonies were screened for Tc sensitivity, which would
indicate that these colonies lost the plasmid. A Tcs Spr colony confirmed with
PCR to have an  fragment substituted for the hopO1-1 operon was designated
UNL137.
Yeast two-hybrid analysis. Protein-protein interactions were determined with
yeast two-hybrid assays that used pEG202, a vector that encodes a LexA DNA
binding domain (DBD) (i.e., the bait vector), and pJG4-5, a vector encoding an
activation domain (AD) (i.e., the fish vector) (13). We made constructs contain-
ing shcO1, shcS1, shcS2, hopO1-1, hopO1-2, hopT1-1, hopT1-2, hopS1, or hopS2
in pEG202 or pJG4-5. The pEG202 constructs, cloned genes, and PCR primer
sets used for cloning are as follows: pLN249, shcO1, and P568/P569; pLN568,
shcS1, and P933/P934; and pLN966, shcS2, and P1260/P951. The pJG4-5 con-
structs, the genes, and the primer sets used are as follows: pLN241, hopT1, and
P570/P571; pLN248, hopO1-1, and P722/P723; pLN250, shcO1, and P568/P569;
pLN428, hopO1-2, and P763/P764; pLN750, shcS1, and P933/P934; pLN752,
hopT1-2, and P1117/P1118; pLN753, hopS1, and P948/P949; pLN967, hopS2, and
P952/P953; and pLN980, shcS2, and P1260/P951. Additional pJG4-5 constructs
were made that corresponded to different regions of HopO1-1. The construct
names, the corresponding HopO1-1 amino acids, and the primer sets used are
the following: pLN625, HopO1-1 amino acids (aa) 1 to 140, and P722/P975;
pLN627, HopO1-1 aa 141 to 283, and P976/P723; pLN716, HopO1-1 aa 190 to
283, and P1036/P723; pLN998, HopO1-1 aa 111 to 175, and P1298/P1299;
pLN999, HopO1-1 aa 71 to 189, and P1034/P1297; pLN1022, HopO1-1 aa 1 to
125, and P722/P1351; pLN1023, HopO1-1 aa 1 to 110, and P722/P1355;
pLN1027, HopO1-1 aa 161 to 283, and P1353/P723; and pLN1460, HopO1-1 aa
1 to 70, and P722/P1677. To test interactions, different combinations of plasmids
were cotransformed into Saccharomyces cerevisiae strain EGY48(pSH18-34) and
the interactions were analyzed using published protocols (32). Briefly, different
combinations of plasmids carried in EGY48(pSH18-34) were analyzed on galac-
tose-containing plates that lacked leucine and contained X-gal. Interactions were
detected based on the ability to rescue leucine auxotrophy and -galactosidase
activity.
Pathogenicity assays. Arabidopsis thaliana Col-0 plants used in pathogenicity
assays were grown in a growth chamber at 23°C with 8 h of light per day. The
ability of DC3000 and derivative strains to grow in planta in Col-0 plants was
determined as described previously (27). Briefly, bacteria were grown at 28°C
overnight on KB agar plates and suspended at an OD600 of 0.2 in 10 mM MgCl2
containing 0.02% Silwet L-77 (Lehle Seeds, Round Rock, TX). Four-week-old
Col-0 plants were dip-inoculated into cell suspensions for 1 m and allowed to dry.
Four leaf disks 0.4 cm2 in size were sampled for each treatment at days 0, 2, and
4 postinoculation and macerated in 1 ml sterile water. Serial dilutions were
plated on KB plates containing the appropriate antibiotics. Plates were incubated
at 28°C for 48 h, after which the colonies were enumerated. The following strains
were used in pathogenicity assays: wild-type DC3000, the DC3000 hrcC mutant,
and the DC3000 hopO1-1 operon mutant UNL137. Complementation of
UNL137 was performed using subclones of the hopO1-1 operon, which included
the following: pLN454 contained the complete hopO1-1 operon in pBBR1MCS5,
which was cloned using primer set P939/P583; pLN256, which contained hopT1-1
and was made with primer set P824/P583; and pLN411, which contained shcO1
and hopO1-1.
RESULTS
ShcO1 facilitates the type III secretion of HopO1-1 and
interacts with HopO1-1 in vivo. HopO1-1 (formerly known as
HopPtoS1 or HopPtoO) is a DC3000 effector that shares sim-
ilarity to ADP ribosyltransferases (34, 59). It was shown to be
secreted via the DC3000 TTSS (59) and translocated into plant
cells (34). hopO1-1 is located on pDC3000A, one of the two
plasmids identified in P. syringae pv. tomato DC3000 (15). The
hopO1-1 operon contains two other genes (Fig. 1A). hopT1-1,
located downstream of hopO1-1, encodes an effector demon-
strated to be translocated (62). We identified an open reading
frame (ORF) upstream of hopO1-1, PSPTOA0017, which
shared the general characteristics of type III chaperones
(TTCs) (71). These characteristics include its gene location, a
small molecular mass (15.6 kDa), and an acidic isoelectric
point (5.5). Moreover, PSPTOA0017 shows a predicted 3-D
structure that is similar to several animal pathogen class 1A
TTCs as determined based on the protein fold recognition
program 3D-PSSM.
To determine whether PSPTOA0017 encoded a TTC that
facilitated the type III secretion of HopO1-1 we made a
DC3000 mutant, UNL137, lacking the complete hopO1-1
operon as described in Materials and Methods. We grew
UNL137 cultures carrying plasmids that contained hopO1-1
(fused to a flag epitope to allow for detection of HopO1-1)
with and without PSPTOA0017 and performed type III secre-
tion assays to determine whether HopO1-1 was secreted in
FIG. 1. ShcO1 facilitates the type III secretion of HopO1-1 and
interacts with HopO1-1 in vivo. (A) Genetic organization of the
HopO1-1 operon. The operon is located on plasmid pDC3000A in
DC3000. The TTC gene shcO1 is depicted with a striped box. The
hopO1-1 and hopT1-1 genes are depicted with a black box and a
hatched box, respectively. The open boxes show the genes flanking the
hopO1-1 operon. The gray box marked with an asterisk between shcO1
and hopO1-1 represents a gene fragment which is homologous to
hopS1, a gene shown in Fig. 2A. (B) Secretion of HopO1-1 in culture
via the DC3000 TTSS is enhanced in the presence of the ShcO1 TTC.
Constructs containing hopO1-1-flag (pLN142) or shcO1/hopO1-1-flag
(pLN411) were electroporated into the DC3000 hopO1-1 operon de-
letion mutant UNL137, which also carried pCPP2318 encoding -lac-
tamase lacking its export signal. Cultures of the above strains were
grown in hrp-inducing fructose medium and separated into cell (C) and
supernatant (S) fractions. Proteins were resolved with SDS-PAGE and
transferred to polyvinylidene difluoride membranes. HopO1-1-F and
-lactamase were detected with anti-FLAG and anti--lactamase an-
tibodies, respectively. (C) ShcO1 coimmunoprecipitates with
HopO1-1. DC3000(pLN142, pLN898) cultures, which expressed
ShcO1-HA and HopO1-1-F, were sonicated, and soluble protein sam-
ples were obtained by centrifugation. Soluble proteins were mixed with
anti-FLAG resin to immunoprecipitate (IP) HopO1-1-F as described
in Materials and Methods. DC3000(pLN898, pML123) and
DC3000(pBBR1MCS1, pLN142) were used as vector controls. Frac-
tions representing the total soluble protein (Lysate), total soluble pro-
tein after treatment with resin (Unbound), the final wash (Wash), and
the proteins that were eluted from the resin (Elution) were subjected
to SDS-PAGE and immunoblotted. ShcO1-HA and HopO1-1-F were
detected with anti-HA and anti-FLAG antibodies, respectively.
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higher amounts when PSPTOA0017 was present. The cultures
were separated into cell and supernatant fractions, and these
samples were subjected to SDS-PAGE and analyzed for the
presence of HopO1-1-FLAG with immunoblots. We found
that a much greater amount of HopO1-1 was found in the
supernatant fraction when PSPTOA0017 was present, as is
consistent with the presumed function of PSPTOA0017 as a
TTC for HopO1-1 (Fig. 1B). In the absence of PSPTOA0017,
only a small amount of HopO1-1 was secreted, which may have
been due to the presence of other homologous TTC genes
present in the genome of DC3000. Hereafter, we refer to
PSPTOA0017 as ShcO1. Similar secretion experiments were
carried out for HopT1-1, and we found that this effector was
secreted in high amounts in the absence of ShcO1, suggesting
that ShcO1 is not a TTC for HopT1-1 (data not shown). In
addition, secretion assays were done to determine whether
ShcO1 was type III secreted and we were unable to detect any
ShcO1 in supernatant fractions, suggesting that it is not se-
creted (data not shown).
To facilitate secretion, TTCs interact directly with their cog-
nate effectors. To determine whether ShcO1 interacted with
HopO1-1, we did coimmunoprecipitation experiments with
DC3000 extracts from cultures expressing ShcO1 fused to an
hemagglutinin (HA) epitope (ShcO1-HA) and/or HopO1-1
fused to the FLAG epitope (HopO1-1-FLAG). When anti-
FLAG resin was incubated with these extracts, ShcO1-HA was
immunoprecipitated along with HopO1-1-FLAG (Fig. 1C).
Importantly, ShcO1-HA did not associate with the anti-FLAG
resin in the absence of HopO1-1-FLAG (Fig. 1C). This indi-
cates that ShcO1 and HopO1-1 interact in vivo, as is consistent
with ShcO1 acting as a TTC for HopO1-1.
Characterization of a chromosomal region in DC3000 that
shares similarity to the hopO1-1 operon. Several genomic in-
vestigations have identified a DC3000 chromosomal region
that contains ORFs homologous to the genes in the hopO1-1
operon (15, 34, 59). This region includes two predicted tran-
scriptional units that have putative promoters containing hrp
boxes, suggesting that they are regulated by the HrpL alterna-
tive sigma factor used in the transcription of many P. syringae
type III genes (40) (Fig. 2A).
One predicted transcriptional unit, referred to here as the
hopS1 operon, contained a putative TTC gene, shcS1, which
encodes a protein that is 79% identical to ShcO1 (Fig. 2A).
The next gene in the operon, hopS1 (formerly named hopP-
toS4), has been shown to encode a translocated effector (62).
A transposon is located downstream of hopS1, followed by an
ORF, PSPTO4595, that shares similarity with the 3 half of
hopO1-1. Another ORF overlapping with PSPTO4595 also
shares similarity with hopO1-1, suggesting that this region has
incurred frameshift mutations and that hopS1 likely represents
a truncated gene. The adjacent downstream ORF, now desig-
nated hopO1-2 (formerly designated hopPtoS3 or hopPtoO2)
(34, 59), encodes a protein that is 75.3% identical to HopO1-1.
Downstream of hopO1-2 is a putative effector gene, hopT1-2,
which would encode a protein that is 71% identical to
HopT1-1. The rest of the putative transcriptional unit contains
PSPTO4592, PSPTO4591, and PSPTO4590. The predicted
protein products of PSPTO4592 and PSPTO4591 are homol-
ogous to different regions of HopO1-1 and HopO1-2 and likely
represent a single coding sequence interrupted with a nonsense
mutation. PSPTO4590 appears to be a truncated hopT1-2 ho-
molog and is probably nonfunctional. The other transcriptional
unit in this DNA region, referred to here as the hopS2 operon
(Fig. 2A), is an apparent two-gene operon that contains a
putative chaperone gene, shcS2, encoding a protein that has
69.2% and 70.3% identity with ShcO1 and ShcS1, respectively,
and a putative effector gene, hopS2, encoding a protein 35.3%
identical to HopS1 (59).
We sought to determine the transcriptional status of the
hopS1 operon, before and after the transposon insertion, as
FIG. 2. RT-PCR experiments indicate that shcS1/hopS1 and shcS2/
hopS2 are transcribed in a type III-dependent manner and that
HopO1-2 and HopT1-2 are both secreted in culture via the DC3000
TTSS. (A) The genetic organization of a cluster of genes in the
DC3000 chromosome which are homologous to shcO1, hopO1-1, or
hopT1-2. The homologous TTC genes, shcS1 and shcS2, are depicted
with striped boxes. The homologous effector genes hopS1 and hopS2
are depicted with stippled boxes. Black boxes depict genes or ORFs
that are homologous to hopO1-2 and hatched boxes depict hopT1-2
and a nearby homologous ORF, PSPTO4590. The open box represents
a transposase that interrupts hopS1 and PSPTO4595. The ORFs with
number designations represent the PSPTO numbers from the data-
bases. The arrows show the predicted orientation of transcription and
the black squares indicate the presence of hrp boxes, which are often
found associated with type III-related promoters. (B) RT-PCR analy-
sis of the DNA region shown in panel A. RNA was isolated from
DC3000 cultures grown in either rich KB medium or hrp-inducing
minimal medium. RT-PCR using RNA from KB-grown cultures with
reverse transcriptase (RT) (lane 1) or without RT (lane 2); RT-PCR
using RNA from hrp-inducing grown cultures with RT (lane 3) or
without RT (lane 4); PCR using DC3000 genomic DNA (lane 5). The
primer sets used were complementary to sequences within the coding
regions of shcS1/hopS1, hopO1-2, or shcS2/hopS2. (C) Immunoblot
analyses were performed cultures of DC3000 or a DC3000 hrcC mu-
tant disabled in type III secretion, carrying either pLN521 (encoding
HopO1-2-FLAG) or pLN567 (encoding HopT1-2-FLAG). Cultures
were separated into cell-bound (C, lanes 1 to 3) or supernatant (S,
lanes 4 to 6) fractions. Lanes 1 and 4, wild-type DC3000; lanes 2 and
5, DC3000(pLN521) (top two blots) or DC3000(pLN567) (bottom two
blots); lanes 3 and 6, DC3000 hrcC(pLN521) (top two blots) or
DC3000 hrcC(pLN567) (bottom two blots). Strains also carried
pCPP2318, which encoded a mature form of -lactamase that should
remain cell bound unless significant nonspecific cell lysis occurred.
Cell-bound and supernatant fractions were concentrated 13.3- and
133-fold, respectively. Anti-FLAG antibodies were used to visualize
HopO1-2-F and HopT1-2-F and -lactamase (-Lac) was detected
with anti--lactamase antibodies.
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well as the hopS2 operon. To do so we did RT-PCR experi-
ments with three different primer sets. The first primer set
spanned the first two genes of the hopS1 operon, shcS1 and
hopS1, the second primer set annealed within the coding re-
gion of hopO1-2, and the third primer set spanned shcS2 and
hopS2 in the hopS2 operon. The results clearly showed that
both shcS1/hopS1 and shcS2/hopS2 were transcribed (Fig. 2B).
We detected RNA for shcS1/hopS1 even in rich medium, al-
though the amount of RNA appeared greater from cultures
grown in hrp-inducing conditions. We detected reduced
amounts of RNA from hopO1-2 in a hrp-independent manner
(Fig. 2B). The transposon may have polar effects and/or there
may be an out-reading promoter within the transposon, sug-
gesting that HopO1-2 and HopT1-2 may be made constitu-
tively in low amounts in DC3000.
To determine whether the HopO1-2 and HopT1-2 proteins
could be secreted via the DC3000 TTSS, we separately cloned
these genes into a broad-host-range plasmid and electropo-
rated the resulting constructs, pLN521 and pLN567, into
DC3000. DC3000(pLN521), expressing HopO1-2, and
DC3000(pLN567), expressing HopT1-2 (which both produced
proteins fused to a C-terminal FLAG epitope), were grown in
hrp-inducing minimal medium and separated into cell and su-
pernatant fractions. Immunoblots using anti-FLAG antibodies
showed that both HopO1-2-FLAG and HopT1-2-FLAG were
found in the supernatant fraction, indicating that both were
secreted via the DC3000 TTSS (Fig. 2C). Therefore, even
though the transcription of these genes is likely to be at a low
level due to the polar effects of the upstream transposon, their
protein products are secreted via the DC3000 TTSS.
HopS2 is well distributed in different P. syringae strains and
is translocated into plant cells. A recent report concluded on
the basis of adenylate cyclase (CyaA) reporter translocation
assays (62) that HopS2 (PSPTO4588) was not translocated into
plant cells. Because our RT-PCR data suggested that the
hopS2 operon was active we were interested in experiments
that further investigated this operon. To determine how com-
mon hopS2 was in other P. syringae strains and other plant
pathogens we did DNA gel blot analyses with total DNA from
different bacterial strains and probed with hopS2. In our survey
we found that hopS2 was present in all the P. syringae pv.
tomato strains (DC3000, Pt23, 3357, and 133) and both P.
syringae pv. maculicola strains tested (84-67 and NCPPB1886)
and in the lone strains tested from P. syringae pathovars phase-
olicola (HB10Y) and tabaci (11528) (Fig. 3A). But hopS2 was
not detected in several P. syringae strains, including pathovar
syringae, glycinea, or pisi (Fig. 3A).
One possible reason that HopS2 was not translocated in the
previous report (62) was that the biochemical characteristics of
its N terminus, which may represent a secretion signal, were
different from the majority of other P. syringae effectors. Spe-
cifically, one difference was that HopS2 lacked a leucine, iso-
leucine, valine, or proline in position 3 or 4 which is present in
other P. syringae effectors (59). Instead, position 3 and 4 are
occupied with a lysine or serine in HopS2 from DC3000. To
determine whether hopS2 alleles from other strains encoded
proteins with similar N-terminal characteristics, we PCR-
cloned hopS2 from the P. syringae pv. maculicola strains 84-67
and NCPPB1886 and P. syringae pv. tomato Pt23 and com-
pletely sequenced both nucleotide strands of each allele. While
there were several conservative amino acid changes within the
predicted HopS2 products, the first 50 amino acids encompass-
ing the N-terminal secretion signal characteristics were iden-
tical, including positions 3 and 4 (data not shown). This sug-
gests that HopS2 may possess different N-terminal
characteristics than other P. syringae effectors and led us to
retest whether HopS2 was translocated into plant cells.
The earlier report that indicated that HopS2 was not trans-
located into plant cells was done only in the presence of its
putative TTC ShcS2 (62). We rationalized that HopS2 was
possibly translocated at a low level into plant cells and not
easily detected. Hence, we retested its translocation in the
FIG. 3. HopS2 and HopS2 secretion signal mutation derivatives
are not detectably secreted in culture via the DC3000 TTSS, but are
translocated into plant cells. (A) Distribution of hopS2 in different P.
syringae strains and other bacterial plant pathogens. Total DNA from
different strains of bacteria was digested with EcoRI and transferred to
nylon membrane and probed with a PCR fragment corresponding to a
region within hopS2. Numbered lanes correspond to total DNA from
the following bacteria: 1, P. syringae pv. tomato DC3000; 2, P. syringae
pv. syringae 61; 3, P. syringae pv. glycinea race 4; P. syringae pv. tomato
Pt23; 5, P. syringae pv. syringae B728a; 6, Erwinia chrysanthemi 3937; 7,
P. syringae pv. maculicola 84-67; 8, P. syringae pv. maculicola
NCPPB1886; 9, P. syringae pv. phaseolicola HB10Y; 10, P. syringae pv.
tabaci 11528; 11, P. syringae pv. tomato 3357; 12, P. syringae pv. tomato
133; 13, Xanthomomas campestris pv. vesicatoria 82-8; 14, P. syringae
pv. pisi 11. Molecular mass markers are indicated in kB on the left.
(B) HopS2-CyaA translocation assays with wild-type HopS2 or a
HopS2 missense mutation derivative altered in its N-terminal secretion
signal in the presence or absence of the ShcS2 TTC. DC3000 cultures
expressing different HopS2-CyaA fusions were infiltrated into Nicoti-
ana benthamiana and assayed for cAMP production 6 h after infiltra-
tion as described in Material and Methods. cAMP levels were reported
in picomoles of cAMP per micrograms of protein with standard errors.
The experiment was performed three times with similar results. Re-
sults indicate that wild-type HopS2 is translocated into plant cells in a
ShcS2-dependent manner and that a HopS2 derivative that has a more
typical N-terminal secretion signal was translocated into plant cells in
higher amounts.
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absence and presence of ShcS2 and assessed HopS2 translo-
cation. We made constructs that expressed HopS2 fused to a
calmodulin-dependent adenylate cyclase (CyaA) and per-
formed CyaA translocation assays (18, 67). In this assay, an
effector-CyaA fusion will produce cyclic AMP (cAMP) only if
it is translocated into eukaryotic cells because they contain
calmodulin. Thus, production of significant levels of cAMP
indicates that the effector-CyaA fusion was translocated into
plant cells. We made constructs that encoded HopS2-CyaA
with and without the candidate ShcS2 TTC. DC3000 strains
expressing ShcS2 and HopS2-CyaA (pLN623) or HopS2-CyaA
alone (pLN624) were infiltrated into N. benthamiana leaves,
and cAMP levels were detected as described in Materials and
Methods. The cAMP levels were significantly higher in leaf
tissue infiltrated with DC3000(pLN623) expressing both ShcS2
and HopS2-CyaA than they were with DC3000(pLN624) ex-
pressing only HopS2-CyaA (Fig. 3B). This indicates on the
basis of CyaA assays (60, 62) that HopS2 is translocated into
plant cells, albeit at a relatively low level compared to amounts
of cAMP produced by other P. syringae effectors. These results
are also consistent with ShcS2 acting as a TTC for HopS2.
To test whether the atypical N-terminal characteristics of
HopS2 contributed to its low level of translocation and
whether the N terminus represented a type III secretion signal,
we made CyaA fusions to a hopS2 derivative that encoded a
HopS2 protein that substituted the fourth serine residue with
isoleucine (S4I). DC3000 carrying constructs that made ShcS2
and HopS2S4I-CyaA were infiltrated into N. benthamiana leaf
tissue, and cAMP assays were performed. In the presence of
ShcS2, the HopS2S4I-CyaA carrying strain produced high lev-
els of cAMP, indicating that this effector-CyaA fusion was
translocated into plant cells in much higher amounts than the
wild-type HopS2-CyaA fusion (Fig. 3B). The infiltration of
DC3000 expressing HopS2S4I-CyaA in the absence of ShcS2
resulted in only a small amount of cAMP produced (Fig. 3B),
which demonstrated that the HopS2 mutation derivative still
maintained its dependence on ShcS2 for translocation.
ShcO1, ShcS1, and ShcS2 interact with each other and with
each other’s cognate effectors in yeast two-hybrid assays. Be-
cause the hopO1-1, hopS1, and hopS2 operons contain TTC
and effector genes that encoded homologous TTCs and effec-
tors, we were interested in determining whether the TTCs
could interact with each other and which effectors interacted
with each TTC. To determine this, we cloned shcO1, shcS1,
and shcS2 into the LexA-based yeast two-hybrid vector
pEG202, resulting in constructs pLN249, pLN568, and
pLN966, respectively. Each construct produced a TTC fused to
the LexA DNA binding domain (DBD). We also cloned TTC
genes and effector genes into an activation domain (AD) vec-
tor, pJG4-5, which produced proteins fused to the B42 AD.
The DBD and AD constructs were expressed in yeast cells with
every possible DBD and AD combination, and the yeast strains
were screened for -galactosidase activity and leucine protot-
rophy. We found that each TTC interacted with itself as well as
with each of the others (Table 2), suggesting that these TTCs
can form homodimers and heterodimers. Each TTC interacted
with its most likely cognate effector (based on the location of
the TTC and effector gene). That is, ShcO1 interacted with
HopO1-1, ShcS1 interacted with HopS1, and ShcS2 interacted
with HopS2 (Table 2). Each TTC also interacted with cognate
effector of each of the others (Table 2). For example, ShcO1
interacted with both HopS1 and HopS2. This was unantici-
pated, since HopO1-1 is not homologous to HopS1 and
HopS2. Each TTC also interacted with HopO1-2 (Table 2),
suggesting that this effector may also be dependent on TTC for
secretion. None of the TTCs interacted with HopT1-1 or
HopT1-2, which both appeared to be secreted via the TTSS
independent of TTCs (Fig. 2C) (62).
ShcS1 and ShcS2 can substitute for ShcO1 in the type III
secretion and translocation of the HopO1-1 effector. To deter-
mine the relevance of the interaction of ShcO1 TTC homologs
with multiple effectors, we tested whether ShcS1 or ShcS2
could substitute for ShcO1 in the type III secretion and trans-
location of HopO1-1. We separately PCR-cloned shcS1 and
shcS2 into a broad-host-range plasmid which already contained
hopO1-1-flag, resulting in constructs pLN1019 and pLN1018,
respectively. When the DC3000 hopO1-1 operon deletion mu-
tant UNL137 expressing HopO1-1-FLAG alone was grown, we
noticed that in addition to full-length HopO1-1-FLAG, a
smaller molecular mass protein band, which likely represented
a HopO1-1-FLAG degradation product, was detected on im-
munoblots using anti-FLAG antibodies (Fig. 4A). This degra-
dation product was not detected in E. coli DH5	 expressing
HopO1-1 from the same construct, suggesting that the appar-
ent proteolysis was specific to P. syringae (Fig. 4A). Interest-
ingly, the apparent HopO1-1-FLAG degradation product was
no longer detectable in samples from UNL137 cultures ex-
pressing HopO1-1-FLAG with ShcO1 or ShcS2 (Fig. 4A).
Moreover, the degradation product was reduced in samples
from UNL137 expressing ShcS1 and HopO1-1-FLAG (Fig.
4A). These data suggest that these TTCs stabilize HopO1-1-
FLAG.
To determine whether ShcS1 and ShcS2 facilitated the type
III secretion of HopO1-1 in culture we performed type III
secretion assays with UNL137 containing different TTC/effec-
tor combinations. Cultures of UNL137 containing constructs
that encoded HopO1-1-FLAG alone (pLN142), ShcO1 and
HopO1-1-FLAG (pLN411), ShcS1 and HopO1-1-FLAG
(pLN1019), or ShcS2 and HopO1-1-FLAG (pLN1018) were
grown in hrp-inducing minimal medium and analyzed for the
secretion of HopO1-1-FLAG. We detected higher levels of
secreted HopO1-1-FLAG from cultures that contained ShcO1,
ShcS1, or ShcS2 than in samples containing only HopO1-1-
FLAG (Fig. 4B). This indicates that ShcS1 and ShcS2 can
TABLE 2. Interactions between ShcO1- and HopO1-1-related
TTCs and effectors in yeast two-hybrid assaysa
DBD-ShcO1 DBD-ShcS1 DBD-ShcS2
AD-vector   
AD-ShcO1   
AD-ShcS1   
AD-ShcS2   
AD-HopO1-1   
AD-HopO1-2   
AD-HopS1   
AD-HopS2   
AD-HopT1-1   
AD-HopT1-2   
a , no interaction; , positive interaction.
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function as a TTC for HopO1-1 and is consistent with their
interaction shown in the yeast two-hybrid assays.
We further tested whether each of the TTCs could enhance
the translocation of HopO1-1 into plant cells by use of CyaA
translocation assays. Constructs were made that contained
hopO1-1 (pLN1077), shcO1 and hopO1-1 (pLN1074), shcS1
and hopO1-1 (pLN1076), or shcS2 and hopO1-1 (pLN1075)
such that the hopO1-1 gene on each construct was in-frame
with cyaA. Thus, each construct when expressed by P. syringae
made a HopO1-1-CyaA fusion alone or with one of the ShcO1
TTC homologs. On the basis of the available draft genome
information for P. syringae pv. syringae B728a, this strain does
not contain any shcO1 homologs; therefore, it was used as a
delivery strain to test whether the translocation of HopO1-1-
CyaA fusions was facilitated by the presence of plasmid-en-
coded ShcO1, ShcS1, or ShcS2. B728a expressing HopO1-1-
CyaA alone had relatively high cAMP levels, suggesting that
this fusion protein was translocated in the absence of TTCs
(Fig. 4C). However, cAMP levels were about three times
greater when ShcO1, ShcS1, or ShcS2 was also present (Fig.
4C), clearly demonstrating that each TTC acted as a TTC for
HopO1-1. We also confirmed that HopS1-CyaA used ShcS1 as
a TTC on the basis of higher cAMP levels when plant tissue
was infiltrated with B728a expressing both ShcS1 and HopS1-
CyaA (108.1  5.8 pmol/cAMP/g) compared to cAMP levels
in plant tissue infiltrated with B728a expressing only HopS1-
CyaA (60.1  7.8 pmol/cAMP/g), clearly demonstrating that
ShcS1 acts as a TTC for HopS1.
ShcO1, ShcS1, and ShcS2 bind to the same middle-third
region of HopO1-1. To determine the TTC binding site within
HopO1-1 we made a series of yeast two-hybrid AD constructs
that contained inserts corresponding to different regions of the
HopO1-1 protein (Fig. 5A). These constructs were trans-
formed into yeast strains that contained constructs that en-
coded ShcO1, ShcS1, or ShcS2 fused to the DBD. Yeast two-
hybrid studies were carried out for both -galactosidase activity
and the rescue of leucine auxotrophy. All TTCs interacted with
the different HopO1-1 truncations similarly. The yeast two-hybrid
results for ShcO1-DBD with different HopO1-1-AD truncations
are shown (Fig. 5A and B). ShcO1-DBD did not interact with the
N-terminal 70 amino acids of HopO1-1 or the C-terminal region
spanning amino acids 190 to 283 (Fig. 5A and B). All HopO1-
1-AD fusion proteins were stably expressed, as determined on the
basis of their detection in yeast extracts by use of immunoblot
analysis with anti-HA antibodies (data not shown), excluding the
possibility that the lack of interaction was due to the instability of
the proteins. The HopO1-1-AD fusion corresponding to the first
125 amino acids interacted with ShcO1-DBD, as did the fusion
corresponding to the last 142 amino acids (amino acids 141 to
283), suggesting that there are ShcO1 binding sites in both of
these HopO1-1 truncations (Fig. 5A and B). The smallest
HopO1-1-AD fusion that showed a strong interaction with ShcO1
was the HopO1-1 region from amino acids 111 to 175. Thus, the
ShcO1 binding sites within HopO1-1 reside in the middle third of
FIG. 4. The ShcO1 homologs ShcS1 and ShcS2 enhanced HopO1-1
type III secretion in culture, protected HopO1-1 from degradation,
and enhanced HopO1-1 translocation into plant cells. (A) A HopO1-1
degradation product is made in the absence of ShcO1 and ShcS2 in the
DC3000 hopO1-1 deletion mutant UNL137 but not in E. coli DH5	.
Bacterial strains carrying either pLN142 (hopO1-1-flag), pLN411
(shcO1, hopO1-1-flag), pLN1018 (shcS2, hopO1-1-flag), or pLN1019
(shcS1, hopO1-1-flag) were lysed in SDS sample buffer and subjected
to SDS-PAGE and immunoblot analysis. Anti-FLAG antibodies were
used to detect HopO1-1-FLAG and the HopO1-1-related degradation
product. In UNL137 lacking ShcO1, a small degradation product of
about 10 kDa in mass was detectable. When ShcO1, ShcS1, or ShcS2
was present in UNL137, the degradation product was no longer de-
tected or was reduced. However, the HopO1-1-related degradation
product was not detected in E. coli DH5	. (B) Type III secretion
assays of HopO1-1 in the absence or presence of ShcO1, ShcS1, or
ShcS2. The DC3000 hopO1-1 deletion mutant UNL137 containing the
following constructs were grown in hrp-inducing medium for type III
secretion assays: pLN142 (hopO1-1-flag); pLN411 (shcO1, hopO1-1-
flag); pLN1018 (shcS2, hopO1-1-flag); or pLN1019 (shcS1, hopO1-1-
flag). Cultures were separated into cell-bound (C) and supernatant
(S) fractions, which were concentrated 13.3- and 133-fold, respectively.
NPTII, which should remain in the cell fraction, was used as a lysis
control. Samples were separated with SDS-PAGE and transferred to a
nylon membrane for immunoblot analysis. HopO1-1-FLAG and
NPTII were detected with anti-FLAG and anti-NPTII antibodies, re-
spectively. (C) HopO1-1-CyaA translocation assays in the presence or
absence of the homologous TTCs ShcO1, ShcS1, or ShcS2. B72Ba
cultures containing different constructs that made HopO1-1 alone
(pLN1077) or with ShcO1 (pLN1074), with ShcS1 (pLN1076), or with
ShcS2 (pLN1075) were infiltrated into N. benthamiana and assayed for
cAMP production 7 h after infiltration as described in Material and
Methods. cAMP levels were reported in picomoles of cAMP per mi-
crograms of protein with standard errors. The experiment was per-
formed three times with similar results. Results indicate that HopO1-1
is translocated into plant cells without a plasmid encoded TTC. How-
ever, when any of the three homologous chaperones were present,
higher amounts of HopO1-1-CyaA were translocated into plant cells.
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HopO1-1. The binding pattern of ShcS1 and ShcS2 to HopO1-1
was the same as seen in the above-described results, indicating
that they bind to the same regions of HopO1-1 (data not shown).
Because ShcO1, ShcS1, and ShcS2 bind to the same region
on HopO1-1 and because HopO1-1 does not share high simi-
larity or identity with HopS1 or HopS2, we wanted to identify
similar regions between these effectors that might represent a
conserved TTC binding site within these effectors. Multiple
protein alignments were done between the smallest region of
HopO1-1 that interacted with ShcO1, ShcS1, and ShcS2 and
regions within HopS1 and HopS2. The HopO1-1 region span-
ning amino acids 105 to 135, which is within the region that
interacted strongly with each TTC (Fig. 5A and B), aligned
best with region spanning amino acids 78 to 107 of HopS1 and
amino acids 82 to 111 of HopS2 (Fig. 5C). These regions were
predicted to have 	-helices and amphipathic regions, which
would be consistent with the TTC interacting with hydrophobic
and polar amino acids exposed on the surface of effectors as
shown in structural studies with other TTC/effector pairs (10,
65, 68). Additional experiments are in progress to determine
the TTC binding regions within HopS1 and HopS2.
A DC3000 hopO1-1 operon mutant is reduced in its ability to
multiply in plant tissue but produced disease symptoms sim-
ilar to those seen with wild-type DC3000. To determine the
contribution of HopO1-1 and HopT1-1 to pathogenicity, A.
thaliana ecotype Col-0 plants were dip-inoculated with the
DC3000 hopO1-1 operon mutant UNL137 as described in Ma-
terials and Methods. The disease symptoms produced by
UNL137 were not significantly different from those seen with
the wild-type DC3000 controls (data not shown). However,
bacterial multiplication was reduced in UNL137 compared to
the in planta growth exhibited by wild-type DC3000 (Fig. 6).
The reduction in bacterial growth was complemented on day 4
when the complete hopO1-1 operon was provided in trans on a
broad-host-range plasmid in UNL137. When shcO1 and
hopO1-1 or hopT1-1 alone was provided in trans to UNL137,
FIG. 5. ShcO1 interacts with a middle region of HopO1-1 in a
LexA-based yeast two-hybrid assay. (A) Schematic representation of
different fragments of HopO1-1 fused to the transcriptional activation
domain (AD). The upper open box represents full-length HopO1-1
protein (283 amino acids). The lower bars represent the series of the
DNA fragments that were cloned into pJG4-5 to construct AD-fusions
and used in yeast two-hybrid assays with ShcO1 fused to the DNA-
binding domain (DBD). The results are represented as follows: , strong
interaction; , no detectable interaction; /, weak interaction.
(B) Yeast strains carrying pEG202::shcO1 (producing DBD-ShcO1) and
pJG4-5 carrying different fragments of hopO1-1 were grown 2 days on the
appropriate medium containing X-Gal. Interactions of different AD-
HopO1-1 fusions with DBD-ShcO1 were scored as follows: dark blue,
strong interaction; pale blue, weak interaction; white, no interaction.
Analogous experiments measuring the rescue of leucine auxotrophy
showed similar results (data not shown). (C) The ShcO1 binding re-
gion of HopO1-1 was compared to HopS1 and HopS2 with DNAstar
Megalign program to identify regions of HopS1 and HopS2 that may
represent a TTC binding region. The regions that aligned the best are
shown. Boxed amino acids represent amino acids that are identical in
each protein and shaded amino acids are conservative changes.
FIG. 6. The DC3000 hopO1-1 operon deletion mutant UNL137 is
significantly reduced in its ability to grow in Arabidopsis leaf tissue. The
following strains were dip-inoculated into A. thaliana Col-0 leaves as
described in the Materials and Methods: Wild-type DC3000, the
DC3000 hrcC mutant defective in the TTSS, the hopO1-1 operon
deletion mutant UNL137, UNL137 carrying the complete hopO1-1
operon (pLN454), UNL137 carrying shcO1 and hopO1-1 (pLN411),
and UNL137 carrying hopT1-1 (pLN256). The results suggest that the
hopO1-1 operon does contribute to bacterial multiplication in planta
and, based on the mutant complementation, HopO1-1 contributes
more to in planta growth than HopT1-1. Disease symptoms produced
by UNL137 were indistinguishable from disease symptoms produced
by wild-type DC3000 (data not shown).
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shcO1 and hopO1-1 restored bacterial multiplication to a
higher level than hopT1-1, suggesting that HopO1-1 contrib-
utes more to pathogenicity than HopT1-1.
DISCUSSION
We have shown that ShcO1, ShcS1, and ShcS2 act as TTCs
and facilitate the type III secretion and/or translocation of
their cognate effectors HopO1-1, HopS1, and HopS2, respec-
tively (Figs. 1, 3 and 4). Additional experiments showed that
ShcO1 coimmunoprecipitated with HopO1-1 (Fig. 1C) and
that all three TTCs stabilized HopO1-1 and enhanced the
secretion and translocation of HopO1-1 (Fig. 4). Yeast two-
hybrid assays showed that each of these TTCs interacted with
the effectors of each of the other as well as the HopO1-1
homolog, HopO1-2 (Table 2). This was surprising since class
1A TTCs are known to interact with only one effector, and
because HopS1 and HopS2 do not share high similarity with
HopO1-1 and HopO1-2, it implied that dissimilar effectors
could maintain TTC specificity. Each TTC also interacted with
the other homologous TTCs consistent with these forming as
either homo- or heterodimers. We used yeast two-hybrid as-
says to define the TTC binding site within HopO1-1 and found
that each TTC bound to the middle third of HopO1-1 (Fig. 5).
Recently, a related study, which was focused on the ShcS1/
HopS1 interaction, showed that ShcO1 could substitute for
ShcS1 in HopS1 translocation (44). This paper also reports
that ShcS1 and ShcO1 interact with each other’s respective
effectors HopO1-1 and HopS1. Additionally, they also showed
that ShcO1 and ShcS1 interacted with themselves as well as
with each other in yeast two-hybrid assays. Our results confirm
these interactions. One curious difference between our results
and theirs is that they were unable to show that ShcS2 inter-
acted with its own effector (HopS2), HopS1, or HopO1-1 in
yeast two-hybrid assays, whereas we found that ShcS2 inter-
acted strongly with these three effectors and HopO1-2. Indeed,
they reported that ShcS2 was unable to substitute for ShcS1 in
HopS1 translocation (44). In contrast, we found that ShcS2
facilitated the translocation of HopS2 and protected HopO1-1
from proteolysis, enhanced secretion of HopO1-1 via the TTSS
in culture, and enhanced the translocation of HopO1-1 into
plant cells (Figs. 3 and 4). Thus, we conclude that ShcS2 is an
active TTC.
HopO1-1 and HopS1 are known to be translocated effectors
(34, 59, 62). However, prior to this report, HopS2 was not
detectably translocated (62). It was speculated that the reason
for this was that HopS2 had atypical N-terminal biochemical
characteristics (62). Most P. syringae TTSS substrates have N
termini that share biochemical characteristics, and these may
be an important part of a type III secretion signal. The DC3000
HopS2 lacked one of these characteristics—the presence of an
aliphatic amino acid (Leu, Ile, or Val) or a Pro in position 3 or
4. Interestingly, we found that if we introduced an aliphatic
amino acid in position 4 of HopS2, much more HopS2 was
translocated into plant cells, as determined on the basis of the
translocation of HopS2-CyaA fusions (Fig. 3B). This supports
the idea that this N-terminal characteristic does function as a
type III secretion signal. It is important to note that the trans-
location of the HopS2 mutation derivatives retained depen-
dence on the TTC ShcS2. This suggests that the N-terminal
secretion signals in P. syringae TTSS substrates are not inde-
pendent of TTC-mediated secretion signals as indicated for
Yersinia TTSS substrates (20).
Transcriptional analyses indicated that the hopO1-1 and
hopS1 operons were transcribed (11, 75). We revisited the
expression of the hopS1 operon because we were interested in
whether the putative effector genes downstream of the trans-
poson in the shcS1 operon were transcribed. We confirmed
that the hrp promoter upstream of the operon is active (Fig.
2B). Importantly, we also found that the hopO1-2 gene down-
stream of the transposon was transcribed, indicating that this
gene is expressed, albeit at apparent lower levels. Additionally,
we also found that the hopS2 operon was transcribed in an
hrp-dependent manner (Fig. 2B), further supporting the idea
that ShcS2 and HopS2 are functional.
We found that hopO1-2, hopS2, and hopT1-2 encoded pro-
teins that were secreted in culture or translocated via the
DC3000 TTSS (Fig. 2C and 3B). This increases the confirmed
inventory of DC3000 Hops to 43. It is likely that the inventory
will reach about 50 Hops, because several other candidate
Hops await testing (21, 43). We have used several methods to
identify hop genes, including searches for hrp promoter and
N-terminal secretion signal characteristics (30, 59). Currently,
the most efficient approach to identify hop genes is to use both
criteria together. Even though the DC3000 Hop inventory is
large, we know little about the effector activities and their plant
targets. The effectors discussed here—HopO1-1 and HopO1-
2—are putative ADP ribosyltransferases, while HopS1,
HopS2, HopT1-1, and HopT1-2 have no significant similarities
to any known genes or proteins in the databases. Of the other
DC3000 effectors, only HopPtoD2 and HopPtoN have con-
firmed enzymatic activities (14, 27, 53).
The amount of redundancy of the genes in the hopO1-1,
hopS1, and hopS2 operons is quite substantial. For example,
there are three sets of effectors encoded that are clearly ho-
mologous (HopS1/HopS2, HopO1-1/HopO1-2, and HopT1-1/
HopT1-2). And HopO1-1, HopS1, and HopS2 are further
linked by utilizing the same TTCs for their secretion. At first
glance, it is surprising how dissimilar effectors could evolve to
use homologous TTCs. One possible explanation is that these
effectors arose from gene duplication events and have since
diverged. Supporting this notion is that the ORF immediately
downstream of the transposon (and other overlapping ORFs)
actually has similarity to hopO1-1 and encodes a protein do-
main for an active site of ADP ribosyltransferases similar to
HopO1-1 and HopO1-2. Therefore, hopS1 may have previ-
ously encoded an effector more similar to HopO1-1 than it
does currently. Further supporting this is that, in between
shcO1 and hopO1-1 on the plasmid, there is a gene fragment
with homology to hopS1. Therefore, it seems likely that the
hopO1-1 operon was in the chromosome near the hopS1
operon or that the hopS1 operon was carried on the plasmid
near hopO1-1.
Once a gene duplication event occurred, mutations may
have arisen in regions important for TTC binding that still
permitted TTC binding. The fact that the regions are dissimilar
seems to suggest that the primary amino acid sequence is not
important for TTC binding. Rather, it may be the mixture of
hydrophobic patches and the polar amino acid residues that
are important for TTC binding, which is supported by the
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structural studies of TTCs bound to their effectors (10, 65, 68).
We have defined the TTC binding site within HopO1-1 and
this region has predicted 	-helices and exposed hydrophobic
and polar amino acids consistent with those found in the struc-
tural studies of other TTC/effector pairs. Currently, we are
defining the TTC binding regions within HopS1 and HopS2 to
define the properties of these regions that provide TTC spec-
ificity. We hope these studies will allow us to exploit the re-
dundancy of P. syringae effectors and TTCs to explore the
molecular details of these interactions.
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